Adamas Pharmaceuticals Inc.

ADMS

30.89

-0.99

-3.1%

After Hours:

30.48

-0.41

-1.3%

Please Login or Register

Login|Register FREE

Stock Price
Open: 31.94
Prev. Close: 31.88
Low/Hi: 30.29 - 31.94
52-Week: 13.50 - 44.00
Volumes
Equity: 921,880
90-Day Avg: 968,596
Option: 452
90-Day Avg: 824
Volatility
Todays Stock Vol: 52.5
20-Day (HV): 52.3
52-Week (HV): 64.8
30-Day IV: 55.2 -4.8
IV Pct Rank: 17% Subdued
Fundamental
Div. Yield:
Earnings: 7-Aug (Est.)
P/E Ratio:
Market Cap: 860.2 M
Short Int Pct: 0.0%
Pct Held By Inst.: 79.0%
Stock Info
Type: Common
Sector: Healthcare
Industry: Drugs - Generic

About ADMS

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on those affected by chronic disorders of the central nervous system. The company achieves this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone or in fixed-dose combination products. Adamas is currently developing its lead wholly-owned product candidate, ADS-5102, for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia, or LID, and is evaluating other potential indications. The company's portfolio also includes two approved products with Forest Laboratories Holdings Limited (a subsidiary of Actavis plc), Namzaric(TM) and Namenda XR(R). Forest is responsible for marketing both products in the United States under an exclusive license from Adamas. For more information, please visit www.adamaspharma.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADMS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 362.1 M 3.62084E+08 203 203 0.05% 0.000492814 376 K 376439
EQWS PowerShares Russell 2000 Equal Weight Portfolio 25.0 M 2.5E+07 1,927 1927 0.04% 0.00038 10 K 9564
IBB iShares Nasdaq Biotechnology Index Fund 9.0 B 8.96125E+09 192 192 0.12% 0.0012 10.4 M 1.03824E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 13.8 B 1.37811E+10 3,460 3460 0.0% 0 550 K 549866
IWC iShares Microcap ETF 991.6 M 9.91612E+08 1,365 1365 0.13% 0.0013 1.3 M 1258690
IWM iShares Russell 2000 ETF 45.9 B 4.58636E+10 1,975 1975 0.02% 0.0002 11.3 M 1.13249E+07
IWN iShares Russell 2000 Value ETF 10.0 B 9.9945E+09 1,392 1392 0.02% 0.0002 2.5 M 2461170
IWO iShares Russell 2000 Growth ETF 10.3 B 1.02907E+10 1,183 1183 0.02% 0.0002 2.5 M 2518230
IWV iShares Russell 3000 ETF 8.4 B 8.39591E+09 2,930 2930 0.0% 0 202 K 201641
SBIO ALPS Medical Breakthroughs ETF 192.1 M 1.92065E+08 97 97 0.58% 0.0058 1.1 M 1113977
UBIO Proshares UltraPro Nasdaq Biotechnology 38.1 M 3.80733E+07 197 197 0.03% 0.000292042 36 K 35578
URTY ProShares UltraPro Russell2000 151.0 M 1.51024E+08 1,985 1985 0.0% 4.86248E-05 25 K 24548
UWM ProShares Ultra Russell2000 238.4 M 2.38449E+08 1,985 1985 0.01% 8.88302E-05 47 K 46736
VHT Vanguard Health Care ETF 7.1 B 7.1E+09 362 362 0.02% 0.00017 1.2 M 1212550
VTHR Vanguard Russell 3000 ETF 352.7 M 3.527E+08 2,725 2725 0.0% 1E-05 4 K 3709
VTI Vanguard Total Stock Market ETF 93.3 B 9.33E+10 3,629 3629 0.0% 2E-05 2.3 M 2255560
VTWG Vanguard Russell 2000 Growth ETF 249.3 M 2.493E+08 1,205 1205 0.03% 0.00025 62 K 62235
VTWO Vanguard Russell 2000 ETF 1.3 B 1.3E+09 2,003 2003 0.02% 0.00024 310 K 310389
VTWV Vanguard Russell 2000 Value ETF 188.8 M 1.888E+08 1,404 1404 0.03% 0.00025 47 K 46725
VXF Vanguard Extended Market ETF 5.9 B 5.9E+09 3,259 3259 0.01% 0.00012 723 K 723239
XBI SPDR Series Trust SPDR S&P Biotech ETF 5.4 B 5.36991E+09 117 117 1.6% 0.015964 86.0 M 8.59711E+07

Wait, Before You Leave...

Want to Know More About ADMS Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon